fanta.bio Sample: CNhs10621
- Species
- human
- CRE Type
- ELA
- Cluster
- 0
- Cell Type Class
- Cardiovascular
17940 enriched TFs, sorted by log₁₀ q-value (most significant first).
| TF | Cell Type | Active overlap | Inactive overlap | log₁₀ p-value | log₁₀ q-value | Fold-enrichment |
|---|---|---|---|---|---|---|
| HIF1A SRX11007095 | HK-2 Kidney | 1855 / 12633 (14.7%) | 778 / 126330 (0.6%) | −324.0 | −324.0 | 23.84 |
| TP53 SRX1547996 | Dermal fibroblast Epidermis | 852 / 12633 (6.7%) | 396 / 126330 (0.3%) | −324.0 | −324.0 | 21.52 |
| TP53 SRX1547998 | Dermal fibroblast Epidermis | 1191 / 12633 (9.4%) | 682 / 126330 (0.5%) | −324.0 | −324.0 | 17.46 |
| DVL1 SRX22740968 | MDA-MB-231 Breast | 1210 / 12633 (9.6%) | 696 / 126330 (0.6%) | −324.0 | −324.0 | 17.39 |
| DVL1 SRX22740969 | MDA-MB-231 Breast | 1702 / 12633 (13.5%) | 1046 / 126330 (0.8%) | −324.0 | −324.0 | 16.27 |
| DVL1 SRX22740970 | MDA-MB-231 Breast | 1655 / 12633 (13.1%) | 1026 / 126330 (0.8%) | −324.0 | −324.0 | 16.13 |
| SCML2 SRX644728 | 293 Kidney | 998 / 12633 (7.9%) | 670 / 126330 (0.5%) | −324.0 | −324.0 | 14.90 |
| FOXP1 SRX736067 | LNCAP Prostate | 1188 / 12633 (9.4%) | 1054 / 126330 (0.8%) | −324.0 | −324.0 | 11.27 |
| MED1 SRX9419944 | BT-474 Breast | 2423 / 12633 (19.2%) | 2401 / 126330 (1.9%) | −324.0 | −324.0 | 10.09 |
| BRD4 SRX9419937 | BT-474 Breast | 2482 / 12633 (19.6%) | 2493 / 126330 (2.0%) | −324.0 | −324.0 | 9.96 |
| MED1 SRX9419947 | BT-474 Breast | 2494 / 12633 (19.7%) | 2516 / 126330 (2.0%) | −324.0 | −324.0 | 9.91 |
| MED1 SRX9419945 | BT-474 Breast | 2426 / 12633 (19.2%) | 2472 / 126330 (2.0%) | −324.0 | −324.0 | 9.81 |
| BRD4 SRX9419935 | BT-474 Breast | 2420 / 12633 (19.2%) | 2477 / 126330 (2.0%) | −324.0 | −324.0 | 9.77 |
| BRD4 SRX9419936 | BT-474 Breast | 2501 / 12633 (19.8%) | 2588 / 126330 (2.0%) | −324.0 | −324.0 | 9.66 |
| BRD4 SRX9419938 | BT-474 Breast | 2463 / 12633 (19.5%) | 2566 / 126330 (2.0%) | −324.0 | −324.0 | 9.60 |
| MED1 SRX9419946 | BT-474 Breast | 2470 / 12633 (19.6%) | 2581 / 126330 (2.0%) | −324.0 | −324.0 | 9.57 |
| EZH2 SRX2146136 | LNCAP Prostate | 5357 / 12633 (42.4%) | 6853 / 126330 (5.4%) | −324.0 | −324.0 | 7.82 |
| BRD4 SRX736201 | 90-8TL Neural | 4060 / 12633 (32.1%) | 5586 / 126330 (4.4%) | −324.0 | −324.0 | 7.27 |
| Epitope tags SRX20419389 | Keratinocytes Epidermis | 1302 / 12633 (10.3%) | 2159 / 126330 (1.7%) | −324.0 | −324.0 | 6.03 |
| HMGB1 SRX2765964 | HUVEC Cardiovascular | 1408 / 12633 (11.1%) | 3861 / 126330 (3.1%) | −316.9 | −313.7 | 3.65 |
| PBX4 SRX2731658 | PC-3 Prostate | 585 / 12633 (4.6%) | 19877 / 126330 (15.7%) | −314.7 | −311.5 | 0.29 |
| MYH11 SRX265221 | ME-1 Blood | 582 / 12633 (4.6%) | 542 / 126330 (0.4%) | −296.5 | −293.3 | 10.74 |
| YAP1 SRX757325 | H2052 Lung | 358 / 12633 (2.8%) | 15326 / 126330 (12.1%) | −290.8 | −287.7 | 0.23 |
| YAP1 SRX757326 | H2052 Lung | 295 / 12633 (2.3%) | 13747 / 126330 (10.9%) | −275.7 | −272.5 | 0.21 |
| HIF1A SRX20663235 | HK-2 Kidney | 415 / 12633 (3.3%) | 216 / 126330 (0.2%) | −268.9 | −265.8 | 19.21 |
| FOS SRX150477 | MCF 10A Breast | 400 / 12633 (3.2%) | 14694 / 126330 (11.6%) | −243.5 | −240.4 | 0.27 |
| FOS SRX150478 | MCF 10A Breast | 443 / 12633 (3.5%) | 15080 / 126330 (11.9%) | −232.5 | −229.4 | 0.29 |
| RUNX1 SRX2513054 | 293 Kidney | 2643 / 12633 (20.9%) | 13234 / 126330 (10.5%) | −229.0 | −225.9 | 2.00 |
| JUN SRX11051031 | hTERT RPE-1 Neural | 676 / 12633 (5.4%) | 18234 / 126330 (14.4%) | −216.9 | −213.9 | 0.37 |
| HMGB1 SRX10567335 | HUVEC Cardiovascular | 1222 / 12633 (9.7%) | 4099 / 126330 (3.2%) | −209.6 | −206.6 | 2.98 |
| TP53 SRX19538279 | Osteoblasts Bone | 355 / 12633 (2.8%) | 242 / 126330 (0.2%) | −207.8 | −204.8 | 14.67 |
| EED SRX8175103 | ES cells Pluripotent stem cell | 1732 / 12633 (13.7%) | 7307 / 126330 (5.8%) | −207.1 | −204.1 | 2.37 |
| JUN SRX11051032 | hTERT RPE-1 Neural | 688 / 12633 (5.4%) | 18076 / 126330 (14.3%) | −207.1 | −204.1 | 0.38 |
| FOXA2 SRX4677296 | CFPAC-1 Pancreas | 422 / 12633 (3.3%) | 13897 / 126330 (11.0%) | −205.5 | −202.5 | 0.30 |
| CHD1 SRX2268291 | Mesenchymal stem cells Others | 1001 / 12633 (7.9%) | 2939 / 126330 (2.3%) | −204.2 | −201.2 | 3.41 |
| AGO2 SRX4708039 | Hep G2 Liver | 1477 / 12633 (11.7%) | 5722 / 126330 (4.5%) | −203.8 | −200.8 | 2.58 |
| FOS SRX4192880 | MCF 10A Breast | 318 / 12633 (2.5%) | 11932 / 126330 (9.4%) | −198.6 | −195.7 | 0.27 |
| TP53 SRX19538274 | U2OS Bone | 300 / 12633 (2.4%) | 155 / 126330 (0.1%) | −194.7 | −191.8 | 19.35 |
| CTNNB1 SRX13991431 | MCF 10A Breast | 314 / 12633 (2.5%) | 190 / 126330 (0.2%) | −192.6 | −189.7 | 16.53 |
| JUN SRX11051045 | hTERT RPE-1 Neural | 690 / 12633 (5.5%) | 17526 / 126330 (13.9%) | −190.3 | −187.4 | 0.39 |
| FOXA1 SRX4815198 | MCF-7 Breast | 717 / 12633 (5.7%) | 17889 / 126330 (14.2%) | −189.5 | −186.6 | 0.40 |
| TP53 SRX19538268 | U2OS Bone | 289 / 12633 (2.3%) | 151 / 126330 (0.1%) | −186.9 | −184.0 | 19.14 |
| JUN SRX17561461 | LPS141 Adipocyte | 272 / 12633 (2.2%) | 10734 / 126330 (8.5%) | −185.6 | −182.8 | 0.25 |
| JUN SRX11051046 | hTERT RPE-1 Neural | 628 / 12633 (5.0%) | 16352 / 126330 (12.9%) | −182.9 | −180.1 | 0.38 |
| CIC SRX13262055 | Astrocytes Neural | 2389 / 12633 (18.9%) | 12507 / 126330 (9.9%) | −182.1 | −179.3 | 1.91 |
| SS18 SRX3468047 | Fibroblasts Others | 546 / 12633 (4.3%) | 15064 / 126330 (11.9%) | −181.3 | −178.5 | 0.36 |
| GATA3 SRX190194 | SK-N-SH Neural | 508 / 12633 (4.0%) | 14392 / 126330 (11.4%) | −178.6 | −175.7 | 0.35 |
| TP53 SRX19538273 | U2OS Bone | 274 / 12633 (2.2%) | 141 / 126330 (0.1%) | −178.1 | −175.3 | 19.43 |
| CHD1 SRX2268289 | Mesenchymal stem cells Others | 484 / 12633 (3.8%) | 764 / 126330 (0.6%) | −177.9 | −175.1 | 6.34 |
| SMARCA2 SRX8119674 | MRC-5 Lung | 516 / 12633 (4.1%) | 14456 / 126330 (11.4%) | −177.0 | −174.2 | 0.36 |
| TP53 SRX19538276 | U2OS Bone | 285 / 12633 (2.3%) | 167 / 126330 (0.1%) | −176.9 | −174.1 | 17.07 |
| FOS SRX150517 | MCF 10A Breast | 358 / 12633 (2.8%) | 11926 / 126330 (9.4%) | −176.6 | −173.8 | 0.30 |
| SMARCC1 SRX11379507 | Liposarcoma, Myxoid Adipocyte | 461 / 12633 (3.6%) | 13586 / 126330 (10.8%) | −176.5 | −173.7 | 0.34 |
| TP53 SRX19538275 | U2OS Bone | 277 / 12633 (2.2%) | 154 / 126330 (0.1%) | −175.3 | −172.5 | 17.99 |
| EED SRX8175102 | ES cells Pluripotent stem cell | 1417 / 12633 (11.2%) | 5879 / 126330 (4.7%) | −172.4 | −169.6 | 2.41 |
| TCF12 SRX190356 | SK-N-SH Neural | 616 / 12633 (4.9%) | 15767 / 126330 (12.5%) | −171.4 | −168.6 | 0.39 |
| 5-mC SRX882968 | LNCAP Prostate | 2190 / 12633 (17.3%) | 11318 / 126330 (9.0%) | −170.7 | −167.9 | 1.93 |
| 5-mC SRX882970 | LNCAP Prostate | 2201 / 12633 (17.4%) | 11414 / 126330 (9.0%) | −170.2 | −167.4 | 1.93 |
| TRP47 SRX4548329 | THP-1 Blood | 2059 / 12633 (16.3%) | 10375 / 126330 (8.2%) | −169.9 | −167.2 | 1.98 |
| TP53 SRX19538280 | Osteoblasts Bone | 282 / 12633 (2.2%) | 181 / 126330 (0.1%) | −169.1 | −166.4 | 15.58 |
| TP53 SRX19538267 | U2OS Bone | 262 / 12633 (2.1%) | 138 / 126330 (0.1%) | −169.0 | −166.2 | 18.99 |
| AR SRX10820653 | LNCAP Prostate | 272 / 12633 (2.2%) | 164 / 126330 (0.1%) | −167.1 | −164.3 | 16.59 |
| JUNB SRX8488073 | SUM 229PE Breast | 414 / 12633 (3.3%) | 12509 / 126330 (9.9%) | −166.5 | −163.7 | 0.33 |
| FOXA1 SRX176862 | MCF-7 Breast | 283 / 12633 (2.2%) | 10262 / 126330 (8.1%) | −164.0 | −161.3 | 0.28 |
| FOXA1 SRX176863 | MCF-7 Breast | 255 / 12633 (2.0%) | 9768 / 126330 (7.7%) | −163.9 | −161.2 | 0.26 |
| CHD1 SRX2268290 | Mesenchymal stem cells Others | 459 / 12633 (3.6%) | 753 / 126330 (0.6%) | −163.8 | −161.1 | 6.10 |
| TP53 SRX19538281 | Osteoblasts Bone | 299 / 12633 (2.4%) | 239 / 126330 (0.2%) | −163.4 | −160.7 | 12.51 |
| JUNB SRX10119396 | MDA-MB-231 Breast | 204 / 12633 (1.6%) | 8792 / 126330 (7.0%) | −161.9 | −159.2 | 0.23 |
| FOS SRX150476 | MCF 10A Breast | 391 / 12633 (3.1%) | 11976 / 126330 (9.5%) | −161.4 | −158.7 | 0.33 |
| CNOT3 SRX886405 | HCT 116 Digestive tract | 1533 / 12633 (12.1%) | 6858 / 126330 (5.4%) | −161.4 | −158.7 | 2.24 |
| JUN SRX6582171 | GM07492 Others | 438 / 12633 (3.5%) | 12704 / 126330 (10.1%) | −160.9 | −158.3 | 0.34 |
| ERG SRX026653 | CD34 Hematopoietic stem cells Blood | 1321 / 12633 (10.5%) | 5465 / 126330 (4.3%) | −160.7 | −158.1 | 2.42 |
| IRF3 SRX11453858 | Hep G2 Liver | 221 / 12633 (1.7%) | 79 / 126330 (0.1%) | −160.3 | −157.6 | 27.97 |
| JUNB SRX8488088 | SUM 229PE Breast | 447 / 12633 (3.5%) | 12815 / 126330 (10.1%) | −160.1 | −157.5 | 0.35 |
| FOXA1 SRX4815197 | MCF-7 Breast | 569 / 12633 (4.5%) | 14665 / 126330 (11.6%) | −159.9 | −157.3 | 0.39 |
| FOXA2 SRX5504125 | CFPAC-1 Pancreas | 268 / 12633 (2.1%) | 9866 / 126330 (7.8%) | −159.7 | −157.0 | 0.27 |
| SREBF2 SRX5359048 | HCC70 Breast | 1354 / 12633 (10.7%) | 5713 / 126330 (4.5%) | −159.0 | −156.4 | 2.37 |
| FOSL2 SRX10640866 | SK-MEL-147 Epidermis | 446 / 12633 (3.5%) | 12733 / 126330 (10.1%) | −158.2 | −155.5 | 0.35 |
| FOXA2 SRX6441753 | CFPAC-1 Pancreas | 285 / 12633 (2.3%) | 10099 / 126330 (8.0%) | −157.7 | −155.0 | 0.28 |
| FOXA1 SRX3931044 | MCF-7 Breast | 495 / 12633 (3.9%) | 13461 / 126330 (10.7%) | −157.4 | −154.7 | 0.37 |
| EP300 SRX2671813 | Fibroblasts Others | 160 / 12633 (1.3%) | 7808 / 126330 (6.2%) | −156.9 | −154.3 | 0.20 |
| BMI1 SRX7196715 | SU-DIPG-IV Neural | 1453 / 12633 (11.5%) | 6428 / 126330 (5.1%) | −155.9 | −153.3 | 2.26 |
| PRRX1 SRX15235713 | Hs 578T Breast | 257 / 12633 (2.0%) | 9531 / 126330 (7.5%) | −155.0 | −152.4 | 0.27 |
| TP53 SRX19538269 | U2OS Bone | 323 / 12633 (2.6%) | 337 / 126330 (0.3%) | −154.5 | −151.9 | 9.58 |
| FOSL2 SRX10640865 | SK-MEL-147 Epidermis | 454 / 12633 (3.6%) | 12732 / 126330 (10.1%) | −154.4 | −151.9 | 0.36 |
| TRIM25 SRX1660873 | Breast cancer cells Breast | 1533 / 12633 (12.1%) | 7011 / 126330 (5.5%) | −154.1 | −151.5 | 2.19 |
| FOSL2 SRX10640867 | SK-MEL-147 Epidermis | 396 / 12633 (3.1%) | 11788 / 126330 (9.3%) | −153.5 | −150.9 | 0.34 |
| CEBPB SRX11379528 | Liposarcoma, Myxoid Adipocyte | 535 / 12633 (4.2%) | 13928 / 126330 (11.0%) | −153.4 | −150.8 | 0.38 |
| SMARCA2 SRX8119677 | MeT-5A Others | 377 / 12633 (3.0%) | 11453 / 126330 (9.1%) | −152.5 | −150.0 | 0.33 |
| JUN SRX883584 | MDA-MB-231 Breast | 360 / 12633 (2.8%) | 11177 / 126330 (8.8%) | −152.4 | −149.8 | 0.32 |
| 5-mC SRX882965 | LNCAP Prostate | 1782 / 12633 (14.1%) | 8803 / 126330 (7.0%) | −152.0 | −149.5 | 2.02 |
| NANOG SRX3288566 | hESC H9 Pluripotent stem cell | 161 / 12633 (1.3%) | 7667 / 126330 (6.1%) | −151.4 | −148.9 | 0.21 |
| Epitope tags SRX10549776 | K-562 Blood | 1045 / 12633 (8.3%) | 3903 / 126330 (3.1%) | −150.6 | −148.1 | 2.68 |
| JUNB SRX10119395 | MDA-MB-231 Breast | 196 / 12633 (1.6%) | 8264 / 126330 (6.5%) | −149.3 | −146.7 | 0.24 |
| RUNX1 SRX2014504 | Jurkat Blood | 1887 / 12633 (14.9%) | 9681 / 126330 (7.7%) | −147.4 | −144.9 | 1.95 |
| FOXA2 SRX6441752 | CFPAC-1 Pancreas | 238 / 12633 (1.9%) | 8948 / 126330 (7.1%) | −146.9 | −144.4 | 0.27 |
| MECOM SRX23677884 | HNT-34 Blood | 1367 / 12633 (10.8%) | 6033 / 126330 (4.8%) | −146.9 | −144.3 | 2.27 |
| CDYL2 SRX8321653 | MCF-7 Breast | 1430 / 12633 (11.3%) | 6460 / 126330 (5.1%) | −146.8 | −144.3 | 2.21 |
| RELA SRX2207673 | HUVEC Cardiovascular | 914 / 12633 (7.2%) | 18998 / 126330 (15.0%) | −146.1 | −143.6 | 0.48 |
| FOXA1 SRX1161177 | MCF-7 Breast | 231 / 12633 (1.8%) | 8801 / 126330 (7.0%) | −146.1 | −143.6 | 0.26 |
| GATA3 SRX190239 | MCF-7 Breast | 348 / 12633 (2.8%) | 10738 / 126330 (8.5%) | −145.0 | −142.5 | 0.32 |
| PTEN SRX5416007 | SMMC-7721 Liver | 1402 / 12633 (11.1%) | 6310 / 126330 (5.0%) | −144.9 | −142.4 | 2.22 |
| SMARCC1 SRX11379511 | Liposarcoma, Myxoid Adipocyte | 316 / 12633 (2.5%) | 10212 / 126330 (8.1%) | −144.9 | −142.4 | 0.31 |
| SMARCA4 SRX5212366 | Mel270 Others | 317 / 12633 (2.5%) | 10214 / 126330 (8.1%) | −144.6 | −142.1 | 0.31 |
| FOXA1 SRX371482 | MCF-7 Breast | 353 / 12633 (2.8%) | 10799 / 126330 (8.5%) | −144.5 | −142.0 | 0.33 |
| MECOM SRX23677885 | HNT-34 Blood | 1376 / 12633 (10.9%) | 6142 / 126330 (4.9%) | −144.5 | −142.0 | 2.24 |
| SMARCA4 SRX5212362 | Mel270 Others | 419 / 12633 (3.3%) | 11844 / 126330 (9.4%) | −144.4 | −141.9 | 0.35 |
| MEAF6 SRX10606584 | GIST-T1 Digestive tract | 1241 / 12633 (9.8%) | 5248 / 126330 (4.2%) | −144.3 | −141.8 | 2.36 |
| FOXA1 SRX6441747 | CFPAC-1 Pancreas | 203 / 12633 (1.6%) | 8241 / 126330 (6.5%) | −144.2 | −141.7 | 0.25 |
| FOSL2 SRX5054309 | Neural progenitor cells Neural | 224 / 12633 (1.8%) | 8610 / 126330 (6.8%) | −144.1 | −141.6 | 0.26 |
| FOSL2 SRX3367141 | SK-MEL-147 Epidermis | 333 / 12633 (2.6%) | 10455 / 126330 (8.3%) | −143.9 | −141.4 | 0.32 |
| FOS SRX4192879 | MCF 10A Breast | 269 / 12633 (2.1%) | 9386 / 126330 (7.4%) | −143.8 | −141.3 | 0.29 |
| MECOM SRX23677896 | HNT-34 Blood | 1646 / 12633 (13.0%) | 8049 / 126330 (6.4%) | −143.0 | −140.5 | 2.04 |
| FOXA1 SRX9419950 | SK-BR-3 Breast | 417 / 12633 (3.3%) | 11743 / 126330 (9.3%) | −142.5 | −140.0 | 0.36 |
| IRF3 SRX11453861 | Hep G2 Liver | 199 / 12633 (1.6%) | 75 / 126330 (0.1%) | −142.3 | −139.9 | 26.53 |
| SMARCC1 SRX11379505 | Liposarcoma, Myxoid Adipocyte | 433 / 12633 (3.4%) | 11982 / 126330 (9.5%) | −142.2 | −139.7 | 0.36 |
| JUNB SRX10119386 | MCF 10A Breast | 204 / 12633 (1.6%) | 8180 / 126330 (6.5%) | −141.6 | −139.1 | 0.25 |
| SMARCA4 SRX5075169 | Neural progenitor cells Neural | 485 / 12633 (3.8%) | 12746 / 126330 (10.1%) | −141.3 | −138.9 | 0.38 |
| MECOM SRX23677897 | HNT-34 Blood | 1590 / 12633 (12.6%) | 7692 / 126330 (6.1%) | −141.3 | −138.8 | 2.07 |
| JUNB SRX8488074 | SUM 229PE Breast | 315 / 12633 (2.5%) | 10067 / 126330 (8.0%) | −141.0 | −138.6 | 0.31 |
| AGO2 SRX6783957 | Hep G2 Liver | 952 / 12633 (7.5%) | 3491 / 126330 (2.8%) | −140.9 | −138.5 | 2.73 |
| PBX3 SRX190343 | SK-N-SH Neural | 525 / 12633 (4.2%) | 13325 / 126330 (10.5%) | −140.9 | −138.5 | 0.39 |
| FOXA1 SRX371483 | MCF-7 Breast | 275 / 12633 (2.2%) | 9395 / 126330 (7.4%) | −140.8 | −138.4 | 0.29 |
| AGO2 SRX6783958 | Hep G2 Liver | 945 / 12633 (7.5%) | 3449 / 126330 (2.7%) | −140.8 | −138.4 | 2.74 |
| SMARCA4 SRX5212371 | Mel270 Others | 345 / 12633 (2.7%) | 10527 / 126330 (8.3%) | −140.2 | −137.8 | 0.33 |
| VGLL1 SRX24602130 | BT-20 Breast | 249 / 12633 (2.0%) | 8918 / 126330 (7.1%) | −139.8 | −137.4 | 0.28 |
| JUNB SRX4192882 | MCF 10A Breast | 175 / 12633 (1.4%) | 7586 / 126330 (6.0%) | −139.7 | −137.2 | 0.23 |
| ESR1 SRX371476 | MCF-7 Breast | 165 / 12633 (1.3%) | 7396 / 126330 (5.9%) | −139.5 | −137.1 | 0.22 |
| YAP1 SRX10119364 | MCF 10A Breast | 185 / 12633 (1.5%) | 7769 / 126330 (6.1%) | −139.5 | −137.1 | 0.24 |
| RELA SRX2207672 | HUVEC Cardiovascular | 1001 / 12633 (7.9%) | 19875 / 126330 (15.7%) | −139.2 | −136.8 | 0.50 |
| SMARCA4 SRX5075170 | Neural progenitor cells Neural | 621 / 12633 (4.9%) | 14647 / 126330 (11.6%) | −138.8 | −136.4 | 0.42 |
| CARM1 SRX10562203 | MDA-MB-231 Breast | 212 / 12633 (1.7%) | 107 / 126330 (0.1%) | −138.8 | −136.4 | 19.81 |
| FOXA2 SRX6441750 | CFPAC-1 Pancreas | 201 / 12633 (1.6%) | 8036 / 126330 (6.4%) | −138.8 | −136.4 | 0.25 |
| AR SRX10820651 | LNCAP Prostate | 274 / 12633 (2.2%) | 257 / 126330 (0.2%) | −138.6 | −136.2 | 10.66 |
| JUND SRX190357 | SK-N-SH Neural | 305 / 12633 (2.4%) | 9819 / 126330 (7.8%) | −138.5 | −136.1 | 0.31 |
| FOXA1 SRX1161173 | MCF-7 Breast | 182 / 12633 (1.4%) | 7684 / 126330 (6.1%) | −138.5 | −136.1 | 0.24 |
| TP53 SRX2585782 | MDA-MB-231 Breast | 460 / 12633 (3.6%) | 12261 / 126330 (9.7%) | −138.4 | −136.0 | 0.38 |
| ATF1 SRX11470446 | Mesenchymal stem cells Others | 635 / 12633 (5.0%) | 14827 / 126330 (11.7%) | −138.2 | −135.9 | 0.43 |
| FOSL2 SRX190296 | SK-N-SH Neural | 326 / 12633 (2.6%) | 10136 / 126330 (8.0%) | −137.7 | −135.4 | 0.32 |
| CEBPB SRX150632 | HeLa Uterus | 577 / 12633 (4.6%) | 13975 / 126330 (11.1%) | −137.7 | −135.4 | 0.41 |
| KAT6A SRX20971022 | Fibroblasts Others | 197 / 12633 (1.6%) | 81 / 126330 (0.1%) | −137.5 | −135.1 | 24.32 |
| WDR5 SRX5416008 | SMMC-7721 Liver | 1382 / 12633 (10.9%) | 6331 / 126330 (5.0%) | −137.4 | −135.1 | 2.18 |
| TLE3 SRX4815191 | MCF-7 Breast | 235 / 12633 (1.9%) | 8577 / 126330 (6.8%) | −136.7 | −134.3 | 0.27 |
| TP53 SRX19538270 | U2OS Bone | 299 / 12633 (2.4%) | 338 / 126330 (0.3%) | −136.7 | −134.3 | 8.85 |
| FOXA1 SRX6441749 | CFPAC-1 Pancreas | 210 / 12633 (1.7%) | 8133 / 126330 (6.4%) | −136.6 | −134.2 | 0.26 |
| MITF SRX1555436 | 501A Epidermis | 1496 / 12633 (11.8%) | 7139 / 126330 (5.7%) | −136.6 | −134.2 | 2.10 |
| SMARCA4 SRX5212357 | Mel270 Others | 358 / 12633 (2.8%) | 10613 / 126330 (8.4%) | −136.5 | −134.1 | 0.34 |
| JUN SRX7277180 | GM07492 Others | 187 / 12633 (1.5%) | 7695 / 126330 (6.1%) | −135.9 | −133.5 | 0.24 |
| FOXA1 SRX371481 | MCF-7 Breast | 262 / 12633 (2.1%) | 9011 / 126330 (7.1%) | −135.8 | −133.5 | 0.29 |
| FOSL1 SRX14181206 | MSK-PCa3 Prostate | 439 / 12633 (3.5%) | 11845 / 126330 (9.4%) | −135.7 | −133.4 | 0.37 |
| FOXA1 SRX1161176 | MCF-7 Breast | 231 / 12633 (1.8%) | 8474 / 126330 (6.7%) | −135.7 | −133.3 | 0.27 |
| MEAF6 SRX10606585 | GIST-T1 Digestive tract | 1323 / 12633 (10.5%) | 5965 / 126330 (4.7%) | −135.6 | −133.3 | 2.22 |
| JUN SRX6582172 | Fibroblasts Others | 320 / 12633 (2.5%) | 9949 / 126330 (7.9%) | −135.0 | −132.7 | 0.32 |
| YAP1 SRX5718140 | 293 Kidney | 436 / 12633 (3.5%) | 11772 / 126330 (9.3%) | −134.9 | −132.6 | 0.37 |
| FOXA1 SRX1161175 | MCF-7 Breast | 169 / 12633 (1.3%) | 7330 / 126330 (5.8%) | −134.8 | −132.4 | 0.23 |
| TRIM25 SRX1660872 | Breast cancer cells Breast | 1283 / 12633 (10.2%) | 5716 / 126330 (4.5%) | −134.6 | −132.3 | 2.24 |
| SMARCA4 SRX5075176 | Neural progenitor cells Neural | 610 / 12633 (4.8%) | 14321 / 126330 (11.3%) | −134.4 | −132.1 | 0.43 |
| ESR1 SRX371478 | MCF-7 Breast | 326 / 12633 (2.6%) | 10012 / 126330 (7.9%) | −133.9 | −131.6 | 0.33 |
| FOXA1 SRX371480 | MCF-7 Breast | 155 / 12633 (1.2%) | 7009 / 126330 (5.5%) | −132.9 | −130.6 | 0.22 |
| DNMT3B SRX3275107 | iPS cells Pluripotent stem cell | 419 / 12633 (3.3%) | 795 / 126330 (0.6%) | −132.9 | −130.5 | 5.27 |
| ESR1 SRX4367193 | MCF-7 Breast | 842 / 12633 (6.7%) | 17477 / 126330 (13.8%) | −132.7 | −130.4 | 0.48 |
| SMARCC1 SRX11379517 | Liposarcoma, Myxoid Adipocyte | 197 / 12633 (1.6%) | 7764 / 126330 (6.1%) | −132.2 | −129.9 | 0.25 |
| JUN SRX9350646 | Melanoma cell line Epidermis | 332 / 12633 (2.6%) | 10047 / 126330 (8.0%) | −132.2 | −129.9 | 0.33 |
| SMARCC1 SRX11379504 | Liposarcoma, Myxoid Adipocyte | 765 / 12633 (6.1%) | 16412 / 126330 (13.0%) | −132.2 | −129.9 | 0.47 |
| GATA3 SRX176864 | MCF-7 Breast | 167 / 12633 (1.3%) | 7213 / 126330 (5.7%) | −132.2 | −129.9 | 0.23 |
| JUN SRX6582163 | BJ-5ta Epidermis | 307 / 12633 (2.4%) | 9620 / 126330 (7.6%) | −131.5 | −129.2 | 0.32 |
| RORC SRX5359052 | HCC70 Breast | 1005 / 12633 (8.0%) | 3974 / 126330 (3.1%) | −131.2 | −128.9 | 2.53 |
| SMARCC1 SRX11379506 | Liposarcoma, Myxoid Adipocyte | 449 / 12633 (3.6%) | 11821 / 126330 (9.4%) | −130.8 | −128.5 | 0.38 |
| FOXA1 SRX9419949 | SK-BR-3 Breast | 370 / 12633 (2.9%) | 10602 / 126330 (8.4%) | −130.7 | −128.4 | 0.35 |
| RAC1 SRX10365541 | MCF-7 Breast | 112 / 12633 (0.9%) | 6094 / 126330 (4.8%) | −130.5 | −128.2 | 0.18 |
| NCOA3 SRX8949280 | ZR-75-1 Breast | 301 / 12633 (2.4%) | 9482 / 126330 (7.5%) | −130.3 | −128.1 | 0.32 |
| ESR1 SRX7624157 | MCF-7 Breast | 670 / 12633 (5.3%) | 15014 / 126330 (11.9%) | −130.3 | −128.0 | 0.45 |
| ERG SRX063922 | K-562 Blood | 1207 / 12633 (9.6%) | 5306 / 126330 (4.2%) | −129.8 | −127.5 | 2.27 |
| NCOA3 SRX8949281 | ZR-75-1 Breast | 301 / 12633 (2.4%) | 9464 / 126330 (7.5%) | −129.8 | −127.5 | 0.32 |
| BMI1 SRX7196721 | SF8628 Neural | 1299 / 12633 (10.3%) | 5944 / 126330 (4.7%) | −129.0 | −126.7 | 2.19 |
| GATA3 SRX5057632 | MCF-7 Breast | 151 / 12633 (1.2%) | 6815 / 126330 (5.4%) | −128.9 | −126.6 | 0.22 |
| JUN SRX4192884 | MCF 10A Breast | 204 / 12633 (1.6%) | 7787 / 126330 (6.2%) | −128.9 | −126.6 | 0.26 |
| ERG SRX063921 | K-562 Blood | 1147 / 12633 (9.1%) | 4935 / 126330 (3.9%) | −128.5 | −126.3 | 2.32 |
| SS18 SRX10640842 | SK-MEL-147 Epidermis | 328 / 12633 (2.6%) | 9861 / 126330 (7.8%) | −128.5 | −126.2 | 0.33 |
| FOXA1 SRX1389381 | CFPAC-1 Pancreas | 213 / 12633 (1.7%) | 7923 / 126330 (6.3%) | −128.1 | −125.8 | 0.27 |
| FOXL2 SRX6957431 | KGN Gonad | 604 / 12633 (4.8%) | 13992 / 126330 (11.1%) | −128.0 | −125.7 | 0.43 |
| AR SRX1067071 | LHSAR Prostate | 526 / 12633 (4.2%) | 12825 / 126330 (10.2%) | −127.0 | −124.7 | 0.41 |
| CEBPB SRX11379527 | Liposarcoma, Myxoid Adipocyte | 462 / 12633 (3.7%) | 11875 / 126330 (9.4%) | −126.9 | −124.6 | 0.39 |
| FOXA1 SRX1787653 | MCF-7 Breast | 195 / 12633 (1.5%) | 7552 / 126330 (6.0%) | −126.5 | −124.3 | 0.26 |
| FOXA1 SRX3923514 | MCF-7 Breast | 258 / 12633 (2.0%) | 8636 / 126330 (6.8%) | −126.3 | −124.1 | 0.30 |
| ESR1 SRX371469 | MCF-7 Breast | 273 / 12633 (2.2%) | 8886 / 126330 (7.0%) | −126.2 | −124.0 | 0.31 |
| FOXA1 SRX825395 | CFPAC-1 Pancreas | 234 / 12633 (1.9%) | 8222 / 126330 (6.5%) | −126.1 | −123.8 | 0.28 |
| FOSL2 SRX10640864 | SK-MEL-147 Epidermis | 351 / 12633 (2.8%) | 10134 / 126330 (8.0%) | −125.9 | −123.7 | 0.35 |
| NCOA3 SRX8949279 | ZR-75-1 Breast | 389 / 12633 (3.1%) | 10690 / 126330 (8.5%) | −124.8 | −122.6 | 0.36 |
| FOXA2 SRX6441755 | CFPAC-1 Pancreas | 187 / 12633 (1.5%) | 7356 / 126330 (5.8%) | −124.8 | −122.5 | 0.25 |
| RORC SRX5359053 | HCC70 Breast | 954 / 12633 (7.6%) | 3769 / 126330 (3.0%) | −124.5 | −122.2 | 2.53 |
| AR SRX1067070 | LHSAR Prostate | 663 / 12633 (5.2%) | 14677 / 126330 (11.6%) | −124.3 | −122.0 | 0.45 |
| BRD4 SRX736204 | 90-8TL Neural | 692 / 12633 (5.5%) | 2226 / 126330 (1.8%) | −123.8 | −121.5 | 3.11 |
| FOXA1 SRX1161187 | ZR-75-1 Breast | 253 / 12633 (2.0%) | 8449 / 126330 (6.7%) | −123.2 | −120.9 | 0.30 |
| Epitope tags SRX8109066 | Gastric cancer cells Digestive tract | 1409 / 12633 (11.2%) | 6841 / 126330 (5.4%) | −122.9 | −120.7 | 2.06 |
| JUN SRX6582165 | BJ-5ta Epidermis | 512 / 12633 (4.1%) | 12463 / 126330 (9.9%) | −122.8 | −120.6 | 0.41 |
| MECOM SRX23677890 | HNT-34 Blood | 1360 / 12633 (10.8%) | 6501 / 126330 (5.1%) | −122.8 | −120.6 | 2.09 |
| FOXA1 SRX3931043 | MCF-7 Breast | 260 / 12633 (2.1%) | 8550 / 126330 (6.8%) | −122.7 | −120.5 | 0.30 |
| SS18 SRX10640843 | SK-MEL-147 Epidermis | 418 / 12633 (3.3%) | 11058 / 126330 (8.8%) | −122.7 | −120.5 | 0.38 |
| TP53 SRX19538282 | Osteoblasts Bone | 250 / 12633 (2.0%) | 249 / 126330 (0.2%) | −122.6 | −120.4 | 10.04 |
| JUNB SRX10119384 | MCF 10A Breast | 146 / 12633 (1.2%) | 6535 / 126330 (5.2%) | −122.6 | −120.4 | 0.22 |
| JUND SRX699738 | HCASMC Cardiovascular | 365 / 12633 (2.9%) | 10231 / 126330 (8.1%) | −122.4 | −120.2 | 0.36 |
| FOXA1 SRX11222442 | MCF-7 Breast | 163 / 12633 (1.3%) | 6830 / 126330 (5.4%) | −121.9 | −119.7 | 0.24 |
| NR3C1 SRX2609659 | HASM2 Lung | 305 / 12633 (2.4%) | 9258 / 126330 (7.3%) | −121.8 | −119.6 | 0.33 |
| FOXA1 SRX11222441 | MCF-7 Breast | 194 / 12633 (1.5%) | 7370 / 126330 (5.8%) | −121.3 | −119.1 | 0.26 |
| MAU2 SRX15710550 | Fibroblasts Others | 450 / 12633 (3.6%) | 11489 / 126330 (9.1%) | −121.2 | −119.0 | 0.39 |
| GRHL3 SRX2582162 | NHEK Epidermis | 816 / 12633 (6.5%) | 2985 / 126330 (2.4%) | −120.6 | −118.4 | 2.73 |
| FOS SRX070879 | HUVEC Cardiovascular | 281 / 12633 (2.2%) | 8829 / 126330 (7.0%) | −120.6 | −118.4 | 0.32 |
| FOXA2 SRX6441754 | CFPAC-1 Pancreas | 185 / 12633 (1.5%) | 7186 / 126330 (5.7%) | −120.4 | −118.2 | 0.26 |
| JUNB SRX8488089 | SUM 229PE Breast | 266 / 12633 (2.1%) | 8560 / 126330 (6.8%) | −119.9 | −117.7 | 0.31 |
| MethylCap SRX014767 | NB-4 Blood | 1288 / 12633 (10.2%) | 6069 / 126330 (4.8%) | −119.8 | −117.6 | 2.12 |
| JUNB SRX10119383 | MCF 10A Breast | 176 / 12633 (1.4%) | 7000 / 126330 (5.5%) | −119.6 | −117.4 | 0.25 |
| JUN SRX6582164 | BJ-5ta Epidermis | 338 / 12633 (2.7%) | 9702 / 126330 (7.7%) | −119.2 | −117.0 | 0.35 |
| YAP1 SRX1038945 | IMR-90 Lung | 190 / 12633 (1.5%) | 7230 / 126330 (5.7%) | −119.0 | −116.8 | 0.26 |
| TEAD1 SRX3401272 | MCF-7 Breast | 194 / 12633 (1.5%) | 7296 / 126330 (5.8%) | −118.9 | −116.7 | 0.27 |
| ATF1 SRX11470450 | Mesenchymal stem cells Others | 524 / 12633 (4.1%) | 12487 / 126330 (9.9%) | −118.8 | −116.6 | 0.42 |
| FOXA1 SRX11222437 | MCF-7 Breast | 183 / 12633 (1.4%) | 7085 / 126330 (5.6%) | −118.3 | −116.1 | 0.26 |
| ESR1 SRX371479 | MCF-7 Breast | 253 / 12633 (2.0%) | 8291 / 126330 (6.6%) | −118.3 | −116.1 | 0.31 |
| FOXA1 SRX3931054 | MCF-7 Breast | 245 / 12633 (1.9%) | 8156 / 126330 (6.5%) | −118.2 | −116.1 | 0.30 |
| FOXA1 SRX3923533 | ZR-75-1 Breast | 285 / 12633 (2.3%) | 8814 / 126330 (7.0%) | −118.1 | −115.9 | 0.32 |
| FOXA1 SRX1161192 | ZR-75-1 Breast | 248 / 12633 (2.0%) | 8196 / 126330 (6.5%) | −118.0 | −115.9 | 0.30 |
| FOXA1 SRX028634 | MCF-7 Breast | 119 / 12633 (0.9%) | 5878 / 126330 (4.7%) | −118.0 | −115.8 | 0.20 |
| FOXA1 SRX8537740 | SUM 44PE Breast | 600 / 12633 (4.7%) | 13535 / 126330 (10.7%) | −117.8 | −115.6 | 0.44 |
| DAXX SRX1021630 | PC-3 Prostate | 273 / 12633 (2.2%) | 8598 / 126330 (6.8%) | −117.6 | −115.5 | 0.32 |
| ARID1A SRX5089376 | MCF-7 Breast | 230 / 12633 (1.8%) | 7877 / 126330 (6.2%) | −117.6 | −115.4 | 0.29 |
| MECOM SRX23677891 | HNT-34 Blood | 1338 / 12633 (10.6%) | 6469 / 126330 (5.1%) | −117.5 | −115.4 | 2.07 |
| TEAD4 SRX10640862 | SK-MEL-147 Epidermis | 426 / 12633 (3.4%) | 10972 / 126330 (8.7%) | −117.0 | −114.9 | 0.39 |
| FOXA1 SRX1787652 | MCF-7 Breast | 151 / 12633 (1.2%) | 6451 / 126330 (5.1%) | −116.7 | −114.6 | 0.23 |
| FOS SRX3322636 | MCF-7 Breast | 166 / 12633 (1.3%) | 6716 / 126330 (5.3%) | −116.4 | −114.3 | 0.25 |
| ESR1 SRX371477 | MCF-7 Breast | 125 / 12633 (1.0%) | 5933 / 126330 (4.7%) | −116.0 | −113.9 | 0.21 |
| YAP1 SRX10119388 | MDA-MB-231 Breast | 185 / 12633 (1.5%) | 7041 / 126330 (5.6%) | −115.9 | −113.7 | 0.26 |
| TET2 SRX1427029 | 293 Kidney | 955 / 12633 (7.6%) | 3928 / 126330 (3.1%) | −115.8 | −113.7 | 2.43 |
| WWTR1 SRX10119367 | MCF 10A Breast | 320 / 12633 (2.5%) | 9288 / 126330 (7.4%) | −115.6 | −113.5 | 0.34 |
| NR3C1 SRX2609661 | HASM2 Lung | 305 / 12633 (2.4%) | 9034 / 126330 (7.2%) | −115.2 | −113.0 | 0.34 |
| MEAF6 SRX10606586 | GIST-T1 Digestive tract | 928 / 12633 (7.3%) | 3768 / 126330 (3.0%) | −115.1 | −113.0 | 2.46 |
| FOXA1 SRX3931055 | MCF-7 Breast | 225 / 12633 (1.8%) | 7710 / 126330 (6.1%) | −115.0 | −112.9 | 0.29 |
| Epitope tags SRX11470534 | Mesenchymal stem cells Others | 509 / 12633 (4.0%) | 12124 / 126330 (9.6%) | −115.0 | −112.8 | 0.42 |
| JUN SRX2355072 | HAEC Cardiovascular | 369 / 12633 (2.9%) | 10029 / 126330 (7.9%) | −114.9 | −112.8 | 0.37 |
| FOXA1 SRX1161174 | MCF-7 Breast | 286 / 12633 (2.3%) | 8709 / 126330 (6.9%) | −114.7 | −112.5 | 0.33 |
| ESR1 SRX7624156 | MCF-7 Breast | 447 / 12633 (3.5%) | 11192 / 126330 (8.9%) | −114.4 | −112.3 | 0.40 |
| FOXA1 SRX1161189 | ZR-75-1 Breast | 252 / 12633 (2.0%) | 8146 / 126330 (6.4%) | −114.4 | −112.3 | 0.31 |
| ARID1A SRX5679788 | 12Z Others | 105 / 12633 (0.8%) | 5478 / 126330 (4.3%) | −113.9 | −111.7 | 0.19 |
| ZFX SRX7805372 | 293 Kidney | 1149 / 12633 (9.1%) | 5250 / 126330 (4.2%) | −113.7 | −111.5 | 2.19 |
| CHD6 SRX17709200 | C4-2 Prostate | 1164 / 12633 (9.2%) | 5362 / 126330 (4.2%) | −113.2 | −111.1 | 2.17 |
| TAZ SRX14181208 | MSK-PCa3 Prostate | 297 / 12633 (2.4%) | 8833 / 126330 (7.0%) | −113.0 | −110.9 | 0.34 |
| ESR1 SRX371471 | ZR-75-1 Breast | 311 / 12633 (2.5%) | 9045 / 126330 (7.2%) | −112.7 | −110.5 | 0.34 |
| CHD6 SRX17709201 | C4-2 Prostate | 1129 / 12633 (8.9%) | 5139 / 126330 (4.1%) | −112.5 | −110.4 | 2.20 |
| FOXA1 SRX15430994 | SK-BR-3 Breast | 279 / 12633 (2.2%) | 8514 / 126330 (6.7%) | −112.3 | −110.1 | 0.33 |
| SS18 SRX10640841 | SK-MEL-147 Epidermis | 406 / 12633 (3.2%) | 10495 / 126330 (8.3%) | −112.2 | −110.1 | 0.39 |
| Epitope tags SRX11470449 | Mesenchymal stem cells Others | 422 / 12633 (3.3%) | 10732 / 126330 (8.5%) | −112.0 | −109.9 | 0.39 |
| ESR1 SRX371470 | ZR-75-1 Breast | 260 / 12633 (2.1%) | 8194 / 126330 (6.5%) | −111.9 | −109.7 | 0.32 |
| FOXA1 SRX9419951 | SK-BR-3 Breast | 367 / 12633 (2.9%) | 9885 / 126330 (7.8%) | −111.7 | −109.6 | 0.37 |
| TEAD1 SRX716558 | SF268 Neural | 133 / 12633 (1.1%) | 5963 / 126330 (4.7%) | −111.7 | −109.6 | 0.22 |
| ARID1A SRX5089385 | MCF-7 Breast | 199 / 12633 (1.6%) | 7158 / 126330 (5.7%) | −111.7 | −109.6 | 0.28 |
| MAML1 SRX8970969 | Squamous cell carcinoma Others | 268 / 12633 (2.1%) | 8312 / 126330 (6.6%) | −111.6 | −109.5 | 0.32 |
| CEBPB SRX150598 | IMR-90 Lung | 573 / 12633 (4.5%) | 12902 / 126330 (10.2%) | −111.5 | −109.4 | 0.44 |
| NR3C1 SRX2609664 | HASM2 Lung | 399 / 12633 (3.2%) | 10362 / 126330 (8.2%) | −111.4 | −109.3 | 0.39 |
| FOXA1 SRX1161190 | ZR-75-1 Breast | 256 / 12633 (2.0%) | 8110 / 126330 (6.4%) | −111.4 | −109.3 | 0.32 |
| EP300 SRX2671792 | Cardiac progenitor cells Cardiovascular | 203 / 12633 (1.6%) | 7217 / 126330 (5.7%) | −111.4 | −109.3 | 0.28 |
| FOXA1 SRX3923529 | ZR-75-1 Breast | 257 / 12633 (2.0%) | 8120 / 126330 (6.4%) | −111.2 | −109.1 | 0.32 |
| ESR1 SRX2943591 | MCF-7 Breast | 190 / 12633 (1.5%) | 6980 / 126330 (5.5%) | −111.1 | −109.0 | 0.27 |
| FOXA1 SRX5323843 | MCF-7 Breast | 134 / 12633 (1.1%) | 5959 / 126330 (4.7%) | −111.0 | −108.9 | 0.22 |
| ARID1A SRX5679787 | 12Z Others | 98 / 12633 (0.8%) | 5252 / 126330 (4.2%) | −111.0 | −108.9 | 0.19 |
| KMT2A SRX2323891 | 293 Kidney | 725 / 12633 (5.7%) | 2590 / 126330 (2.1%) | −111.0 | −108.9 | 2.80 |
| RELA SRX5938177 | FaDu Others | 255 / 12633 (2.0%) | 8082 / 126330 (6.4%) | −111.0 | −108.9 | 0.32 |
| TEAD4 SRX10640861 | SK-MEL-147 Epidermis | 303 / 12633 (2.4%) | 8857 / 126330 (7.0%) | −111.0 | −108.9 | 0.34 |
| ZFX SRX7805370 | 293 Kidney | 850 / 12633 (6.7%) | 3356 / 126330 (2.7%) | −110.6 | −108.5 | 2.53 |
| ESR2 SRX8272750 | HT-29 Digestive tract | 368 / 12633 (2.9%) | 742 / 126330 (0.6%) | −110.6 | −108.5 | 4.96 |
| STAT5B SRX831881 | CD8+ T cells Blood | 188 / 12633 (1.5%) | 128 / 126330 (0.1%) | −110.2 | −108.1 | 14.69 |
| FOXA2 SRX5504126 | CFPAC-1 Pancreas | 168 / 12633 (1.3%) | 6561 / 126330 (5.2%) | −110.2 | −108.1 | 0.26 |
| FOXA1 SRX3923528 | ZR-75-1 Breast | 180 / 12633 (1.4%) | 6774 / 126330 (5.4%) | −110.1 | −108.0 | 0.27 |
| FOSL2 SRX190204 | A549 Lung | 280 / 12633 (2.2%) | 8457 / 126330 (6.7%) | −110.1 | −108.0 | 0.33 |
| FOXA1 SRX1161188 | ZR-75-1 Breast | 198 / 12633 (1.6%) | 7086 / 126330 (5.6%) | −110.0 | −107.9 | 0.28 |
| NANOG SRX5286327 | ES cells Pluripotent stem cell | 196 / 12633 (1.6%) | 7047 / 126330 (5.6%) | −110.0 | −107.9 | 0.28 |
| FOXA1 SRX1447317 | MCF-7 Breast | 178 / 12633 (1.4%) | 6726 / 126330 (5.3%) | −109.8 | −107.7 | 0.26 |
| ESR1 SRX20282961 | MCF-7 Breast | 372 / 12633 (2.9%) | 9856 / 126330 (7.8%) | −108.9 | −106.8 | 0.38 |
| DNA-RNA hybrid SRX21658478 | U2OS Bone | 428 / 12633 (3.4%) | 1025 / 126330 (0.8%) | −108.8 | −106.7 | 4.18 |
| FOXA1 SRX1787651 | MCF-7 Breast | 152 / 12633 (1.2%) | 6218 / 126330 (4.9%) | −108.6 | −106.5 | 0.24 |
| SMARCA4 SRX8566546 | 786-O Kidney | 992 / 12633 (7.9%) | 18400 / 126330 (14.6%) | −108.4 | −106.3 | 0.54 |
| YAP1 SRX10119387 | MDA-MB-231 Breast | 207 / 12633 (1.6%) | 7180 / 126330 (5.7%) | −108.2 | −106.2 | 0.29 |
| TP53 SRX19538271 | U2OS Bone | 416 / 12633 (3.3%) | 975 / 126330 (0.8%) | −108.2 | −106.1 | 4.27 |
| ESR1 SRX176860 | MCF-7 Breast | 472 / 12633 (3.7%) | 11320 / 126330 (9.0%) | −108.2 | −106.1 | 0.42 |
| GATA2 SRX3503584 | Endometrial stromal cells Uterus | 320 / 12633 (2.5%) | 9018 / 126330 (7.1%) | −108.0 | −105.9 | 0.35 |
| FOS SRX150664 | HUVEC Cardiovascular | 386 / 12633 (3.1%) | 10035 / 126330 (7.9%) | −107.9 | −105.8 | 0.38 |
| ESR1 SRX176861 | MCF-7 Breast | 478 / 12633 (3.8%) | 11394 / 126330 (9.0%) | −107.8 | −105.7 | 0.42 |
| FOXA1 SRX028635 | MCF-7 Breast | 133 / 12633 (1.1%) | 5836 / 126330 (4.6%) | −107.7 | −105.6 | 0.23 |
| FOXA1 SRX1787655 | MCF-7 Breast | 132 / 12633 (1.0%) | 5817 / 126330 (4.6%) | −107.6 | −105.5 | 0.23 |
| FOXA1 SRX3923518 | MCF-7 Breast | 189 / 12633 (1.5%) | 6844 / 126330 (5.4%) | −107.4 | −105.3 | 0.28 |
| FOXA1 SRX3931033 | MCF-7 Breast | 170 / 12633 (1.3%) | 6507 / 126330 (5.2%) | −107.3 | −105.3 | 0.26 |
| SMARCA4 SRX15419260 | 786-O Kidney | 995 / 12633 (7.9%) | 18388 / 126330 (14.6%) | −107.3 | −105.2 | 0.54 |
| Epitope tags SRX11470532 | Mesenchymal stem cells Others | 377 / 12633 (3.0%) | 9852 / 126330 (7.8%) | −106.6 | −104.6 | 0.38 |
| EP300 SRX2194265 | SUM 159PT Breast | 455 / 12633 (3.6%) | 11006 / 126330 (8.7%) | −106.4 | −104.3 | 0.41 |
| FOXA1 SRX3931032 | MCF-7 Breast | 157 / 12633 (1.2%) | 6236 / 126330 (4.9%) | −106.2 | −104.1 | 0.25 |
| FOXA1 SRX100454 | T-47D Breast | 384 / 12633 (3.0%) | 9943 / 126330 (7.9%) | −106.2 | −104.1 | 0.39 |
| FOXA1 SRX1161191 | ZR-75-1 Breast | 228 / 12633 (1.8%) | 7465 / 126330 (5.9%) | −106.0 | −104.0 | 0.31 |
| WWTR1 SRX10119378 | MCF 10A Breast | 314 / 12633 (2.5%) | 8857 / 126330 (7.0%) | −105.9 | −103.9 | 0.35 |
| FOXA1 SRX3923517 | MCF-7 Breast | 202 / 12633 (1.6%) | 7020 / 126330 (5.6%) | −105.8 | −103.8 | 0.29 |
| FOXA1 SRX15430993 | SK-BR-3 Breast | 258 / 12633 (2.0%) | 7952 / 126330 (6.3%) | −105.8 | −103.8 | 0.32 |
| CEBPB SRX190345 | MCF-7 Breast | 219 / 12633 (1.7%) | 7305 / 126330 (5.8%) | −105.7 | −103.6 | 0.30 |
| RAC1 SRX10365543 | MCF-7 Breast | 147 / 12633 (1.2%) | 6031 / 126330 (4.8%) | −105.4 | −103.3 | 0.24 |
| NKX2-1 SRX366169 | NCI-H441 Lung | 352 / 12633 (2.8%) | 9419 / 126330 (7.5%) | −105.2 | −103.1 | 0.37 |
| ESR1 SRX20282960 | MCF-7 Breast | 347 / 12633 (2.7%) | 9341 / 126330 (7.4%) | −105.1 | −103.1 | 0.37 |
| FOS SRX7760064 | CFPAC-1 Pancreas | 232 / 12633 (1.8%) | 7486 / 126330 (5.9%) | −104.7 | −102.6 | 0.31 |
| FOXA1 SRX5203303 | MCF-7 Breast | 87 / 12633 (0.7%) | 4840 / 126330 (3.8%) | −104.5 | −102.4 | 0.18 |
| BRD4 SRX612504 | LX2 Liver | 137 / 12633 (1.1%) | 5816 / 126330 (4.6%) | −104.5 | −102.4 | 0.24 |
| EP300 SRX150579 | HeLa Uterus | 191 / 12633 (1.5%) | 6784 / 126330 (5.4%) | −104.4 | −102.4 | 0.28 |
| DOT1L SRX10606581 | GIST-T1 Digestive tract | 1485 / 12633 (11.8%) | 7865 / 126330 (6.2%) | −104.4 | −102.3 | 1.89 |
| SMARCA4 SRX5075175 | Neural progenitor cells Neural | 445 / 12633 (3.5%) | 10775 / 126330 (8.5%) | −104.3 | −102.2 | 0.41 |
| AR SRX1067067 | LHSAR Prostate | 505 / 12633 (4.0%) | 11645 / 126330 (9.2%) | −104.2 | −102.2 | 0.43 |
| FOXA1 SRX8537741 | SUM 44PE Breast | 483 / 12633 (3.8%) | 11326 / 126330 (9.0%) | −104.2 | −102.2 | 0.43 |
| TET2 SRX2014505 | Jurkat Blood | 1888 / 12633 (14.9%) | 10941 / 126330 (8.7%) | −103.9 | −101.9 | 1.73 |
| FOXA1 SRX3923516 | MCF-7 Breast | 208 / 12633 (1.6%) | 7055 / 126330 (5.6%) | −103.8 | −101.8 | 0.29 |
| GRHL3 SRX2582161 | NHEK Epidermis | 673 / 12633 (5.3%) | 2397 / 126330 (1.9%) | −103.4 | −101.4 | 2.81 |
| FOXA1 SRX3923532 | ZR-75-1 Breast | 188 / 12633 (1.5%) | 6699 / 126330 (5.3%) | −103.4 | −101.4 | 0.28 |
| NKX2-1 SRX2164786 | A549 Lung | 492 / 12633 (3.9%) | 11424 / 126330 (9.0%) | −103.4 | −101.3 | 0.43 |
| NR3C1 SRX2609665 | HASM2 Lung | 327 / 12633 (2.6%) | 8966 / 126330 (7.1%) | −103.3 | −101.3 | 0.36 |
| FOXA1 SRX11222438 | MCF-7 Breast | 148 / 12633 (1.2%) | 5979 / 126330 (4.7%) | −103.2 | −101.2 | 0.25 |
| ESR1 SRX371468 | MCF-7 Breast | 195 / 12633 (1.5%) | 6810 / 126330 (5.4%) | −103.1 | −101.1 | 0.29 |
| FOSL2 SRX5054308 | Neural progenitor cells Neural | 211 / 12633 (1.7%) | 7072 / 126330 (5.6%) | −102.8 | −100.8 | 0.30 |
| EP300 SRX176885 | MCF-7 Breast | 145 / 12633 (1.1%) | 5915 / 126330 (4.7%) | −102.8 | −100.8 | 0.25 |
| ARID1A SRX5089379 | MCF-7 Breast | 293 / 12633 (2.3%) | 8413 / 126330 (6.7%) | −102.8 | −100.8 | 0.35 |
| SMAD3 SRX11483609 | Keratinocytes Epidermis | 421 / 12633 (3.3%) | 10362 / 126330 (8.2%) | −102.7 | −100.7 | 0.41 |
| STAT3 SRX150479 | MCF 10A Breast | 278 / 12633 (2.2%) | 8166 / 126330 (6.5%) | −102.6 | −100.6 | 0.34 |
| PHF6 SRX11508321 | G-401 Kidney | 1113 / 12633 (8.8%) | 5248 / 126330 (4.2%) | −102.5 | −100.5 | 2.12 |
| BRD1 SRX286203 | RKO Digestive tract | 805 / 12633 (6.4%) | 3219 / 126330 (2.5%) | −102.2 | −100.2 | 2.50 |
| ESR1 SRX20282939 | MCF-7 Breast | 350 / 12633 (2.8%) | 9277 / 126330 (7.3%) | −102.2 | −100.2 | 0.38 |
| FOXA1 SRX5323845 | MCF-7 Breast | 98 / 12633 (0.8%) | 4986 / 126330 (3.9%) | −101.8 | −99.8 | 0.20 |
| FOXA1 SRX15430999 | T-47D Breast | 328 / 12633 (2.6%) | 8924 / 126330 (7.1%) | −101.8 | −99.7 | 0.37 |
| FOXA1 SRX3923519 | MCF-7 Breast | 177 / 12633 (1.4%) | 6452 / 126330 (5.1%) | −101.7 | −99.7 | 0.27 |
| STAT3 SRX150630 | MCF 10A Breast | 278 / 12633 (2.2%) | 8134 / 126330 (6.4%) | −101.6 | −99.6 | 0.34 |
| Epitope tags SRX8080565 | Mammary gland adenocarcinoma Breast | 139 / 12633 (1.1%) | 5764 / 126330 (4.6%) | −101.5 | −99.5 | 0.24 |
| DNMT3B SRX3275108 | iPS cells Pluripotent stem cell | 312 / 12633 (2.5%) | 575 / 126330 (0.5%) | −101.4 | −99.4 | 5.43 |
| DDIT3 SRX11379509 | Liposarcoma, Myxoid Adipocyte | 224 / 12633 (1.8%) | 7244 / 126330 (5.7%) | −101.4 | −99.4 | 0.31 |
| GATA3 SRX6712581 | MCF-7 Breast | 245 / 12633 (1.9%) | 7590 / 126330 (6.0%) | −101.4 | −99.4 | 0.32 |
| FOXA1 SRX1787654 | MCF-7 Breast | 97 / 12633 (0.8%) | 4953 / 126330 (3.9%) | −101.3 | −99.3 | 0.20 |
| SREBF2 SRX5359049 | HCC70 Breast | 855 / 12633 (6.8%) | 3555 / 126330 (2.8%) | −101.2 | −99.2 | 2.41 |
| JUND SRX150408 | HeLa Uterus | 266 / 12633 (2.1%) | 7925 / 126330 (6.3%) | −101.2 | −99.2 | 0.34 |
| FOXL2 SRX6957477 | KGN Gonad | 311 / 12633 (2.5%) | 8639 / 126330 (6.8%) | −101.2 | −99.2 | 0.36 |
| FOXA2 SRX6441751 | CFPAC-1 Pancreas | 123 / 12633 (1.0%) | 5452 / 126330 (4.3%) | −101.1 | −99.1 | 0.23 |
| KDM1A SRX10637290 | MDA-MB-231 Breast | 389 / 12633 (3.1%) | 9824 / 126330 (7.8%) | −101.0 | −99.0 | 0.40 |
| BMI1 SRX644729 | 293 Kidney | 175 / 12633 (1.4%) | 124 / 126330 (0.1%) | −101.0 | −99.0 | 14.11 |
| ESR1 SRX371467 | MCF-7 Breast | 323 / 12633 (2.6%) | 8812 / 126330 (7.0%) | −100.8 | −98.8 | 0.37 |
| FOXA1 SRX9419952 | SK-BR-3 Breast | 285 / 12633 (2.3%) | 8217 / 126330 (6.5%) | −100.8 | −98.8 | 0.35 |
| FOXA1 SRX1389379 | CFPAC-1 Pancreas | 193 / 12633 (1.5%) | 6698 / 126330 (5.3%) | −100.8 | −98.8 | 0.29 |
| TEAD4 SRX10640860 | SK-MEL-147 Epidermis | 421 / 12633 (3.3%) | 10289 / 126330 (8.1%) | −100.7 | −98.7 | 0.41 |
| ESR1 SRX20282972 | MCF-7 Breast | 343 / 12633 (2.7%) | 9106 / 126330 (7.2%) | −100.4 | −98.4 | 0.38 |
| FOXA2 SRX2368889 | Ker-CT Epidermis | 244 / 12633 (1.9%) | 7543 / 126330 (6.0%) | −100.4 | −98.4 | 0.32 |
| CEBPB SRX2194249 | SUM 159PT Breast | 294 / 12633 (2.3%) | 8337 / 126330 (6.6%) | −100.2 | −98.3 | 0.35 |
| FOXA1 SRX5203307 | MCF-7 Breast | 77 / 12633 (0.6%) | 4500 / 126330 (3.6%) | −99.9 | −98.0 | 0.17 |
| FOSL1 SRX190212 | HCT 116 Digestive tract | 351 / 12633 (2.8%) | 9196 / 126330 (7.3%) | −99.6 | −97.6 | 0.38 |
| NR1H3 SRX1538760 | HT-29 Digestive tract | 289 / 12633 (2.3%) | 8236 / 126330 (6.5%) | −99.6 | −97.6 | 0.35 |
| LEO1 SRX1873456 | SEM Blood | 1010 / 12633 (8.0%) | 4616 / 126330 (3.7%) | −99.3 | −97.3 | 2.19 |
| HOXC5 SRX2731653 | PC-3 Prostate | 240 / 12633 (1.9%) | 7435 / 126330 (5.9%) | −99.2 | −97.3 | 0.32 |
| TLE3 SRX4815192 | MCF-7 Breast | 275 / 12633 (2.2%) | 7996 / 126330 (6.3%) | −99.1 | −97.1 | 0.34 |
| ESR1 SRX1531791 | MCF-7 Breast | 303 / 12633 (2.4%) | 8437 / 126330 (6.7%) | −99.0 | −97.1 | 0.36 |
| BRPF3 SRX796085 | RKO Digestive tract | 730 / 12633 (5.8%) | 2810 / 126330 (2.2%) | −98.9 | −97.0 | 2.60 |
| GATA3 SRX5457550 | MCF-7 Breast | 334 / 12633 (2.6%) | 8912 / 126330 (7.1%) | −98.9 | −97.0 | 0.37 |
| JUN SRX699737 | HCASMC Cardiovascular | 195 / 12633 (1.5%) | 6670 / 126330 (5.3%) | −98.9 | −96.9 | 0.29 |
| FOXA1 SRX190181 | A549 Lung | 220 / 12633 (1.7%) | 7086 / 126330 (5.6%) | −98.7 | −96.7 | 0.31 |
| CHD7 SRX3581507 | iPS cells Pluripotent stem cell | 245 / 12633 (1.9%) | 7488 / 126330 (5.9%) | −98.3 | −96.4 | 0.33 |
| ARID1A SRX5089382 | MCF-7 Breast | 210 / 12633 (1.7%) | 6905 / 126330 (5.5%) | −98.2 | −96.3 | 0.30 |
| ESR1 SRX194572 | MCF-7 Breast | 202 / 12633 (1.6%) | 6763 / 126330 (5.4%) | −98.1 | −96.1 | 0.30 |
| ESR1 SRX10365536 | MCF-7 Breast | 161 / 12633 (1.3%) | 6047 / 126330 (4.8%) | −97.9 | −96.0 | 0.27 |
| CEBPB SRX2194250 | SUM 159PT Breast | 369 / 12633 (2.9%) | 9405 / 126330 (7.4%) | −97.9 | −96.0 | 0.39 |
| DNMT3B SRX2862488 | hESC HUES8 Pluripotent stem cell | 313 / 12633 (2.5%) | 604 / 126330 (0.5%) | −97.8 | −95.8 | 5.18 |
| FOXA1 SRX3931056 | MCF-7 Breast | 173 / 12633 (1.4%) | 6252 / 126330 (4.9%) | −97.6 | −95.6 | 0.28 |
| MethylCap SRX014766 | NB-4 Blood | 1114 / 12633 (8.8%) | 5371 / 126330 (4.3%) | −97.5 | −95.6 | 2.07 |
| TEAD1 SRX1011298 | HuCCT1 Liver | 126 / 12633 (1.0%) | 5393 / 126330 (4.3%) | −97.3 | −95.3 | 0.23 |
| TEAD1 SRX14688734 | HUVEC Cardiovascular | 269 / 12633 (2.1%) | 7831 / 126330 (6.2%) | −97.1 | −95.2 | 0.34 |
| NFIC SRX190336 | SK-N-SH Neural | 433 / 12633 (3.4%) | 10318 / 126330 (8.2%) | −97.0 | −95.1 | 0.42 |
| FOXA2 SRX2368888 | Ker-CT Epidermis | 291 / 12633 (2.3%) | 8172 / 126330 (6.5%) | −96.9 | −95.0 | 0.36 |
| WWTR1 SRX10119390 | MDA-MB-231 Breast | 112 / 12633 (0.9%) | 5112 / 126330 (4.0%) | −96.8 | −94.9 | 0.22 |
| FOXA1 SRX3923515 | MCF-7 Breast | 168 / 12633 (1.3%) | 6136 / 126330 (4.9%) | −96.8 | −94.9 | 0.27 |
| FOXA1 SRX5203294 | MCF-7 Breast | 79 / 12633 (0.6%) | 4455 / 126330 (3.5%) | −96.8 | −94.9 | 0.18 |
| NR3C1 SRX2609662 | HASM2 Lung | 369 / 12633 (2.9%) | 9363 / 126330 (7.4%) | −96.8 | −94.8 | 0.39 |
| FOXA1 SRX3923530 | ZR-75-1 Breast | 198 / 12633 (1.6%) | 6649 / 126330 (5.3%) | −96.6 | −94.7 | 0.30 |
| BRPF3 SRX796084 | RKO Digestive tract | 1021 / 12633 (8.1%) | 4751 / 126330 (3.8%) | −96.5 | −94.6 | 2.15 |
| TLE3 SRX4815194 | SUM 149PT Breast | 233 / 12633 (1.8%) | 7225 / 126330 (5.7%) | −96.5 | −94.5 | 0.32 |
| FOXA1 SRX5323846 | MCF-7 Breast | 111 / 12633 (0.9%) | 5078 / 126330 (4.0%) | −96.3 | −94.4 | 0.22 |
| FOXA1 SRX3931073 | MCF-7 Breast | 176 / 12633 (1.4%) | 6255 / 126330 (5.0%) | −96.2 | −94.3 | 0.28 |
| FOSL1 SRX17608312 | T24 Others | 116 / 12633 (0.9%) | 5170 / 126330 (4.1%) | −96.2 | −94.2 | 0.22 |
| JUNB SRX10119385 | MCF 10A Breast | 135 / 12633 (1.1%) | 5522 / 126330 (4.4%) | −96.2 | −94.2 | 0.24 |
| FOXA1 SRX1961157 | T-47D Breast | 336 / 12633 (2.7%) | 8839 / 126330 (7.0%) | −96.1 | −94.2 | 0.38 |
| CEBPA SRX4705113 | MOLM-13 Blood | 706 / 12633 (5.6%) | 14081 / 126330 (11.1%) | −95.9 | −94.0 | 0.50 |
| ELF3 SRX1389380 | CFPAC-1 Pancreas | 368 / 12633 (2.9%) | 9314 / 126330 (7.4%) | −95.9 | −93.9 | 0.40 |
| BRD4 SRX327751 | U-87 MG Neural | 852 / 12633 (6.7%) | 16007 / 126330 (12.7%) | −95.9 | −93.9 | 0.53 |
| ESR1 SRX2897220 | Breast cancer cells Breast | 1106 / 12633 (8.8%) | 5358 / 126330 (4.2%) | −95.7 | −93.8 | 2.06 |
| FOSL1 SRX2585779 | MDA-MB-231 Breast | 149 / 12633 (1.2%) | 5763 / 126330 (4.6%) | −95.7 | −93.8 | 0.26 |
| CEBPA SRX2630241 | Hep G2 Liver | 379 / 12633 (3.0%) | 9472 / 126330 (7.5%) | −95.7 | −93.7 | 0.40 |
| FOXA1 SRX100506 | Hep G2 Liver | 415 / 12633 (3.3%) | 10002 / 126330 (7.9%) | −95.6 | −93.7 | 0.41 |
| RNF2 SRX18954719 | SCC-25 Others | 413 / 12633 (3.3%) | 9967 / 126330 (7.9%) | −95.5 | −93.5 | 0.41 |
| WAS SRX5371250 | GM11518 Blood | 786 / 12633 (6.2%) | 3220 / 126330 (2.5%) | −95.4 | −93.5 | 2.44 |
| FOXA1 SRX1161203 | T-47D Breast | 220 / 12633 (1.7%) | 6974 / 126330 (5.5%) | −95.4 | −93.4 | 0.32 |
| KAT7 SRX101303 | RKO Digestive tract | 899 / 12633 (7.1%) | 3957 / 126330 (3.1%) | −95.2 | −93.3 | 2.27 |
| Epitope tags SRX10549778 | K-562 Blood | 772 / 12633 (6.1%) | 3135 / 126330 (2.5%) | −95.2 | −93.3 | 2.46 |
| FOS SRX7760063 | CFPAC-1 Pancreas | 192 / 12633 (1.5%) | 6490 / 126330 (5.1%) | −94.9 | −92.9 | 0.30 |
| EP300 SRX100540 | SK-N-SH Neural | 451 / 12633 (3.6%) | 10496 / 126330 (8.3%) | −94.8 | −92.9 | 0.43 |
| YAP1 SRX1038944 | IMR-90 Lung | 115 / 12633 (0.9%) | 5106 / 126330 (4.0%) | −94.8 | −92.8 | 0.23 |
| PHF6 SRX11508322 | G-401 Kidney | 635 / 12633 (5.0%) | 2302 / 126330 (1.8%) | −94.7 | −92.8 | 2.76 |
| STAT3 SRX2020842 | HCC70 Breast | 550 / 12633 (4.4%) | 11891 / 126330 (9.4%) | −94.6 | −92.7 | 0.46 |
| MCM7 SRX8970972 | Squamous cell carcinoma Others | 349 / 12633 (2.8%) | 8978 / 126330 (7.1%) | −94.6 | −92.7 | 0.39 |
| FOXA1 SRX15430987 | MDA-MB-453 Breast | 451 / 12633 (3.6%) | 10483 / 126330 (8.3%) | −94.6 | −92.6 | 0.43 |
| SMARCA4 SRX5982340 | A549 Lung | 125 / 12633 (1.0%) | 5283 / 126330 (4.2%) | −94.4 | −92.5 | 0.24 |
| FOXA1 SRX3923531 | ZR-75-1 Breast | 172 / 12633 (1.4%) | 6127 / 126330 (4.8%) | −94.4 | −92.5 | 0.28 |
| ESR1 SRX371474 | BT-474 Breast | 142 / 12633 (1.1%) | 5595 / 126330 (4.4%) | −94.4 | −92.5 | 0.25 |
| PRMT1 SRX3642947 | Keratinocytes Epidermis | 177 / 12633 (1.4%) | 6212 / 126330 (4.9%) | −94.3 | −92.4 | 0.28 |
| ESR1 SRX2943589 | MCF-7 Breast | 156 / 12633 (1.2%) | 5843 / 126330 (4.6%) | −94.3 | −92.4 | 0.27 |
| FOS SRX3322637 | MCF-7 Breast | 167 / 12633 (1.3%) | 6036 / 126330 (4.8%) | −94.2 | −92.2 | 0.28 |
| FOXA1 SRX8537737 | MCF-7 Breast | 111 / 12633 (0.9%) | 5010 / 126330 (4.0%) | −94.1 | −92.2 | 0.22 |
| ELF3 SRX825394 | CFPAC-1 Pancreas | 507 / 12633 (4.0%) | 11262 / 126330 (8.9%) | −94.1 | −92.2 | 0.45 |
| EP300 SRX22550927 | CDS1 Bone | 479 / 12633 (3.8%) | 10864 / 126330 (8.6%) | −94.0 | −92.1 | 0.44 |
| DNA-RNA hybrid SRX20083260 | SH-SY5Y Neural | 600 / 12633 (4.7%) | 2109 / 126330 (1.7%) | −94.0 | −92.1 | 2.84 |
| FOXA1 SRX1961158 | T-47D Breast | 308 / 12633 (2.4%) | 8324 / 126330 (6.6%) | −93.8 | −91.9 | 0.37 |
| ESR1 SRX4367192 | MCF-7 Breast | 627 / 12633 (5.0%) | 12901 / 126330 (10.2%) | −93.4 | −91.5 | 0.49 |
| Epitope tags SRX11470445 | Mesenchymal stem cells Others | 398 / 12633 (3.2%) | 9665 / 126330 (7.7%) | −93.4 | −91.5 | 0.41 |
| FOXA1 SRX8083099 | CAMA-1 Breast | 294 / 12633 (2.3%) | 8093 / 126330 (6.4%) | −93.4 | −91.5 | 0.36 |
| ESR1 SRX194569 | MCF-7 Breast | 337 / 12633 (2.7%) | 8750 / 126330 (6.9%) | −93.3 | −91.4 | 0.39 |
| CEBPB SRX11379518 | Liposarcoma, Myxoid Adipocyte | 535 / 12633 (4.2%) | 1749 / 126330 (1.4%) | −93.2 | −91.3 | 3.06 |
| DNA-RNA hybrid SRX21658481 | U2OS Bone | 410 / 12633 (3.2%) | 1088 / 126330 (0.9%) | −93.1 | −91.2 | 3.77 |
| EP300 SRX2194266 | SUM 159PT Breast | 540 / 12633 (4.3%) | 11687 / 126330 (9.3%) | −93.1 | −91.2 | 0.46 |
| BRD4 SRX327752 | U-87 MG Neural | 563 / 12633 (4.5%) | 11999 / 126330 (9.5%) | −92.9 | −91.0 | 0.47 |
| FOXA2 SRX3230382 | Hep G2 Liver | 434 / 12633 (3.4%) | 10154 / 126330 (8.0%) | −92.4 | −90.5 | 0.43 |
| MITF SRX7368255 | Hermes 3C Epidermis | 876 / 12633 (6.9%) | 16150 / 126330 (12.8%) | −92.3 | −90.4 | 0.54 |
| ARID1A SRX5089388 | MCF-7 Breast | 159 / 12633 (1.3%) | 5834 / 126330 (4.6%) | −92.2 | −90.4 | 0.27 |
| FOXL2 SRX5342375 | SVOG-3e Gonad | 250 / 12633 (2.0%) | 7355 / 126330 (5.8%) | −92.2 | −90.3 | 0.34 |
| ARID1A SRX5089391 | MCF-7 Breast | 177 / 12633 (1.4%) | 6145 / 126330 (4.9%) | −92.2 | −90.3 | 0.29 |
| ESR1 SRX20282954 | MCF-7 Breast | 357 / 12633 (2.8%) | 9007 / 126330 (7.1%) | −92.2 | −90.3 | 0.40 |
| TFEB SRX6743819 | iPS cells Pluripotent stem cell | 1032 / 12633 (8.2%) | 4927 / 126330 (3.9%) | −92.1 | −90.2 | 2.09 |
| ESR1 SRX10365532 | MCF-7 Breast | 172 / 12633 (1.4%) | 6051 / 126330 (4.8%) | −91.9 | −90.1 | 0.28 |
| EP300 SRX190219 | SK-N-SH Neural | 319 / 12633 (2.5%) | 8420 / 126330 (6.7%) | −91.8 | −90.0 | 0.38 |
| CEBPB SRX1027438 | Mesenchymal stem cells Others | 405 / 12633 (3.2%) | 9708 / 126330 (7.7%) | −91.8 | −89.9 | 0.42 |
| NR3C1 SRX19024866 | MCF-7 Breast | 105 / 12633 (0.8%) | 4822 / 126330 (3.8%) | −91.6 | −89.7 | 0.22 |
| STAT3 SRX150536 | MCF 10A Breast | 358 / 12633 (2.8%) | 8999 / 126330 (7.1%) | −91.6 | −89.7 | 0.40 |
| FOXA1 SRX1447316 | MCF-7 Breast | 132 / 12633 (1.0%) | 5323 / 126330 (4.2%) | −91.5 | −89.6 | 0.25 |
| JUNB SRX4677294 | CFPAC-1 Pancreas | 202 / 12633 (1.6%) | 6547 / 126330 (5.2%) | −91.5 | −89.6 | 0.31 |
| KMT2A SRX2281249 | SEM Blood | 1351 / 12633 (10.7%) | 7238 / 126330 (5.7%) | −91.4 | −89.6 | 1.87 |
| EP300 SRX1012648 | MCF-7 Breast | 150 / 12633 (1.2%) | 5641 / 126330 (4.5%) | −91.3 | −89.4 | 0.27 |
| NR1H3 SRX1538763 | HT-29 Digestive tract | 308 / 12633 (2.4%) | 8230 / 126330 (6.5%) | −91.2 | −89.4 | 0.37 |
| Epitope tags SRX392691 | T3M-1 Cl-10 Others | 146 / 12633 (1.2%) | 85 / 126330 (0.1%) | −91.1 | −89.2 | 17.18 |
| CBFB SRX265218 | ME-1 Blood | 1025 / 12633 (8.1%) | 4904 / 126330 (3.9%) | −91.1 | −89.2 | 2.09 |
| Epitope tags SRX2745846 | MCF 10A Breast | 211 / 12633 (1.7%) | 6679 / 126330 (5.3%) | −91.0 | −89.2 | 0.32 |
| NANOG SRX10445309 | Neural crest cells Neural | 177 / 12633 (1.4%) | 6102 / 126330 (4.8%) | −90.9 | −89.0 | 0.29 |
| FOXA1 SRX3931031 | MCF-7 Breast | 147 / 12633 (1.2%) | 5571 / 126330 (4.4%) | −90.7 | −88.9 | 0.26 |
| Epitope tags SRX15939724 | RD Muscle | 288 / 12633 (2.3%) | 7899 / 126330 (6.3%) | −90.6 | −88.8 | 0.36 |
| SP1 SRX190269 | A549 Lung | 465 / 12633 (3.7%) | 10526 / 126330 (8.3%) | −90.6 | −88.7 | 0.44 |
| NR3C1 SRX2609666 | HASM2 Lung | 309 / 12633 (2.4%) | 8225 / 126330 (6.5%) | −90.6 | −88.7 | 0.38 |
| EP300 SRX027482 | hESC H9 Pluripotent stem cell | 284 / 12633 (2.2%) | 7834 / 126330 (6.2%) | −90.5 | −88.6 | 0.36 |
| ESR1 SRX330069 | MCF-7 Breast | 196 / 12633 (1.6%) | 6404 / 126330 (5.1%) | −90.3 | −88.4 | 0.31 |
| TEAD4 SRX10640863 | SK-MEL-147 Epidermis | 435 / 12633 (3.4%) | 10084 / 126330 (8.0%) | −90.2 | −88.4 | 0.43 |
| RELA SRX7054617 | HAEC Cardiovascular | 391 / 12633 (3.1%) | 9434 / 126330 (7.5%) | −90.0 | −88.2 | 0.41 |
| FOXA1 SRX8537736 | MCF-7 Breast | 111 / 12633 (0.9%) | 4886 / 126330 (3.9%) | −90.0 | −88.2 | 0.23 |
| WWTR1 SRX10119368 | MCF 10A Breast | 228 / 12633 (1.8%) | 6926 / 126330 (5.5%) | −90.0 | −88.2 | 0.33 |
| ESR1 SRX371475 | BT-474 Breast | 165 / 12633 (1.3%) | 5858 / 126330 (4.6%) | −89.8 | −88.0 | 0.28 |
| BRPF3 SRX796086 | RKO Digestive tract | 964 / 12633 (7.6%) | 4513 / 126330 (3.6%) | −89.8 | −87.9 | 2.14 |
| ESR1 SRX20282946 | MCF-7 Breast | 194 / 12633 (1.5%) | 6344 / 126330 (5.0%) | −89.5 | −87.7 | 0.31 |
| NANOG SRX5286326 | hESC WIBR2 Pluripotent stem cell | 274 / 12633 (2.2%) | 7632 / 126330 (6.0%) | −89.3 | −87.5 | 0.36 |
| MYOCD SRX5598318 | A549 Lung | 1180 / 12633 (9.3%) | 6046 / 126330 (4.8%) | −89.3 | −87.4 | 1.95 |
| FOXA1 SRX190282 | A549 Lung | 230 / 12633 (1.8%) | 6922 / 126330 (5.5%) | −89.1 | −87.2 | 0.33 |
| ESR1 SRX1161185 | ZR-75-1 Breast | 158 / 12633 (1.3%) | 5709 / 126330 (4.5%) | −89.0 | −87.2 | 0.28 |
| FOXA1 SRX6441748 | CFPAC-1 Pancreas | 108 / 12633 (0.9%) | 4795 / 126330 (3.8%) | −88.8 | −86.9 | 0.23 |
| ESR1 SRX330070 | MCF-7 Breast | 168 / 12633 (1.3%) | 5874 / 126330 (4.6%) | −88.7 | −86.9 | 0.29 |
| CXXC1 SRX1424886 | SEM Blood | 992 / 12633 (7.9%) | 4730 / 126330 (3.7%) | −88.7 | −86.9 | 2.10 |
| FOXA1 SRX3931083 | MCF-7 Breast | 186 / 12633 (1.5%) | 6180 / 126330 (4.9%) | −88.6 | −86.8 | 0.30 |
| GATA3 SRX15946407 | MDA-MB-453 Breast | 381 / 12633 (3.0%) | 9228 / 126330 (7.3%) | −88.6 | −86.8 | 0.41 |
| FOXA1 SRX13814018 | 5637 Others | 212 / 12633 (1.7%) | 6610 / 126330 (5.2%) | −88.5 | −86.7 | 0.32 |
| GATA3 SRX11149846 | MDA-MB-453 Breast | 381 / 12633 (3.0%) | 9224 / 126330 (7.3%) | −88.5 | −86.6 | 0.41 |
| TEAD1 SRX7807114 | Unclassified Unclassified | 172 / 12633 (1.4%) | 5932 / 126330 (4.7%) | −88.4 | −86.6 | 0.29 |
| ESR1 SRX330067 | MCF-7 Breast | 297 / 12633 (2.4%) | 7955 / 126330 (6.3%) | −88.3 | −86.5 | 0.37 |
| SMARCA4 SRX8588624 | Pulmonary artery endothelial cells Cardiovascular | 561 / 12633 (4.4%) | 11776 / 126330 (9.3%) | −88.3 | −86.5 | 0.48 |
| YAP1 SRX10119363 | MCF 10A Breast | 140 / 12633 (1.1%) | 5368 / 126330 (4.2%) | −88.2 | −86.4 | 0.26 |
| DNA-RNA hybrid SRX20083264 | SH-SY5Y Neural | 493 / 12633 (3.9%) | 1581 / 126330 (1.3%) | −88.2 | −86.3 | 3.12 |
| VGLL1 SRX18013277 | FULVR Breast | 139 / 12633 (1.1%) | 5347 / 126330 (4.2%) | −88.1 | −86.3 | 0.26 |
| JUNB SRX2443774 | A549 Lung | 142 / 12633 (1.1%) | 5397 / 126330 (4.3%) | −88.1 | −86.3 | 0.26 |
| GATAD2A SRX2636506 | Hep G2 Liver | 418 / 12633 (3.3%) | 9753 / 126330 (7.7%) | −88.1 | −86.3 | 0.43 |
| FOXA1 SRX8083098 | CAMA-1 Breast | 268 / 12633 (2.1%) | 7491 / 126330 (5.9%) | −88.0 | −86.2 | 0.36 |
| CEBPB SRX3584202 | Epididymis Gonad | 305 / 12633 (2.4%) | 8064 / 126330 (6.4%) | −88.0 | −86.2 | 0.38 |
| RELA SRX7054661 | HAEC Cardiovascular | 530 / 12633 (4.2%) | 11334 / 126330 (9.0%) | −88.0 | −86.1 | 0.47 |
| CDK9 SRX7366783 | MCF-7 Breast | 156 / 12633 (1.2%) | 117 / 126330 (0.1%) | −87.9 | −86.1 | 13.33 |
| JUN SRX2355073 | HAEC Cardiovascular | 414 / 12633 (3.3%) | 9683 / 126330 (7.7%) | −87.9 | −86.1 | 0.43 |
| ATF1 SRX11470442 | Mesenchymal stem cells Others | 414 / 12633 (3.3%) | 9685 / 126330 (7.7%) | −87.9 | −86.1 | 0.43 |
| GFP SRX6949256 | HeLa Uterus | 360 / 12633 (2.8%) | 8886 / 126330 (7.0%) | −87.7 | −85.9 | 0.41 |
| Epitope tags SRX392692 | T3M-1 Cl-10 Others | 137 / 12633 (1.1%) | 75 / 126330 (0.1%) | −87.4 | −85.6 | 18.27 |
| FOXA1 SRX6860635 | T-47D Breast | 248 / 12633 (2.0%) | 7155 / 126330 (5.7%) | −87.4 | −85.6 | 0.35 |
| SMAD3 SRX366168 | NCI-H441 Lung | 288 / 12633 (2.3%) | 7780 / 126330 (6.2%) | −87.4 | −85.6 | 0.37 |
| FOXA1 SRX5124035 | 22Rv1 Prostate | 420 / 12633 (3.3%) | 9746 / 126330 (7.7%) | −87.3 | −85.5 | 0.43 |
| EP300 SRX1012643 | MCF-7 Breast | 116 / 12633 (0.9%) | 4897 / 126330 (3.9%) | −87.2 | −85.4 | 0.24 |
| FOXA2 SRX100448 | Hep G2 Liver | 366 / 12633 (2.9%) | 8954 / 126330 (7.1%) | −87.2 | −85.4 | 0.41 |
| NR3C1 SRX8520809 | SUM 159PT Breast | 295 / 12633 (2.3%) | 7875 / 126330 (6.2%) | −87.0 | −85.2 | 0.37 |
| ARID1A SRX5089380 | MCF-7 Breast | 117 / 12633 (0.9%) | 4909 / 126330 (3.9%) | −87.0 | −85.2 | 0.24 |
| EP300 SRX10976625 | A549 Lung | 201 / 12633 (1.6%) | 6369 / 126330 (5.0%) | −86.9 | −85.0 | 0.32 |
| TAL1 SRX393518 | Primary endothelial cells Cardiovascular | 470 / 12633 (3.7%) | 10446 / 126330 (8.3%) | −86.9 | −85.0 | 0.45 |
| FOXA2 SRX3644342 | BJ Epidermis | 477 / 12633 (3.8%) | 10534 / 126330 (8.3%) | −86.6 | −84.8 | 0.45 |
| NCOA3 SRX4663589 | MCF-7 Breast | 88 / 12633 (0.7%) | 4339 / 126330 (3.4%) | −86.6 | −84.7 | 0.20 |
| EP300 SRX1012644 | MCF-7 Breast | 148 / 12633 (1.2%) | 5451 / 126330 (4.3%) | −86.3 | −84.5 | 0.27 |
| NR2F2 SRX190293 | MCF-7 Breast | 351 / 12633 (2.8%) | 8695 / 126330 (6.9%) | −86.3 | −84.5 | 0.40 |
| EP300 SRX10976215 | A549 Lung | 310 / 12633 (2.5%) | 8077 / 126330 (6.4%) | −86.3 | −84.4 | 0.38 |
| ESR1 SRX10365535 | MCF-7 Breast | 271 / 12633 (2.1%) | 7474 / 126330 (5.9%) | −86.2 | −84.4 | 0.36 |
| ESR1 SRX10365533 | MCF-7 Breast | 156 / 12633 (1.2%) | 5583 / 126330 (4.4%) | −86.1 | −84.3 | 0.28 |
| ATF3 SRX1384025 | HCT 116 Digestive tract | 205 / 12633 (1.6%) | 6411 / 126330 (5.1%) | −86.1 | −84.3 | 0.32 |
| SMAD3 SRX148895 | LX2 Liver | 77 / 12633 (0.6%) | 4104 / 126330 (3.2%) | −86.0 | −84.2 | 0.19 |
Showing first 500 of 17940 rows.